2023
The mortality burden of cachexia in patients with non-small cell lung cancer: A meta-analysis.
Bonomi P, Crawford J, Dunne R, Roeland E, Smoyer K, Siddiqui M, McRae T, Rossulek M, Revkin J, Tarasenko L. The mortality burden of cachexia in patients with non-small cell lung cancer: A meta-analysis. Journal Of Clinical Oncology 2023, 41: e24075-e24075. DOI: 10.1200/jco.2023.41.16_suppl.e24075.Peer-Reviewed Original ResearchNon-small cell lung cancerInternational consensus criteriaCell lung cancerOverall survivalSubgroup analysisWeight lossLung cancerStatistical heterogeneityTreatment of NSCLCInferior overall survivalImpact of cachexiaRisk of mortalityFunnel plot analysisHigher mortality riskPrevious weight lossHigh statistical heterogeneitySystematic literature reviewRandom-effects modelBase-case analysisSubstantial publication biasMeta-analysis resultsPoor outcomeMortality burdenCachexiaMortality risk
2022
1616P The mortality burden of cachexia in patients with non-small cell lung cancer: A systematic literature review
Bonomi P, Crawford J, Dunne R, Smoyer K, McRae T, Rossulek M, Revkin J, Tarasenko L. 1616P The mortality burden of cachexia in patients with non-small cell lung cancer: A systematic literature review. Annals Of Oncology 2022, 33: s1281. DOI: 10.1016/j.annonc.2022.07.1919.Peer-Reviewed Original Research1263O Evaluation of weight gain and overall survival of male vs. female patients with advanced non-small cell lung cancer (NSCLC) receiving first-line chemotherapy
Roeland E, Fintelmann F, Yang R, Tarasenko L, McRae T, Revkin J, Bonomi P. 1263O Evaluation of weight gain and overall survival of male vs. female patients with advanced non-small cell lung cancer (NSCLC) receiving first-line chemotherapy. Annals Of Oncology 2022, 33: s1125. DOI: 10.1016/j.annonc.2022.07.1396.Peer-Reviewed Original Research